首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of cancer research and therapeutics

缩写:J CANCER RES THER

ISSN:0973-1482

e-ISSN:1998-4138

IF/分区:1.3/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引5193
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Balbir Singh,Gaganpreet Singh,Arun Singh Oinam et al. Balbir Singh et al.
Purpose/objective(s): This study aimed to estimate the fitting parameters of sigmoidal dose-response (SDR) curve of radiation-induced acute oral and pharyngeal mucositis in head-and-neck (H and N) cancer patients treated ...
Ashwini S Shinde,Vijay D Mendhulkar Ashwini S Shinde
Introduction: Medicinal plants are the major natural resources for the treatment of human ailments including cancer therapy. The current cancer treatments such as surgery, radiation, and chemotherapy affect normal cells t...
S Sujatha,Asha Iyengar,S Pruthvish et al. S Sujatha et al.
Aims and objectives: Tobacco dependence is widely prevalent and a harmful chronic disorder. Achieving long-term tobacco abstinence is an important public health goal. This study aims to assess the long-term effectiveness ...
Nitin R Kakade,Abhishek Das,Rajesh Kumar et al. Nitin R Kakade et al.
Aim: Inw nanoparticles-aided radiotherapy, the radiation sensitivity of tumor is increased with the infusion of nanoparticles in tumor. This therapeutic modality is capable of delivering enhanced dose to tumor, without ex...
Prathiksha Pai,Shreekant K Kittur Prathiksha Pai
Context: The present study concentrates on the need for a novel tumor marker in breast carcinoma, which could be the hepatocyte growth factor (HGF). It is a fibroblast-derived growth factor which acts on cells of mainly e...
Ahmet Gulmez Ahmet Gulmez
Background: Breast cancer (BC) is one of the most common cancers worldwide. In recent years, numerous non-chemotherapy agents have been developed for BC treatment, including targeted agents, new hormonal therapies, and im...
Josipa Jović Zlatović,Tomislav Omrčen,Inga Marijanović et al. Josipa Jović Zlatović et al.
Pazopanib is an oral multitargeting tyrosine kinase inhibitor (TKI) of vascular endothelial growth factor receptors (VEGFRs), approved as the first-line treatment of metastatic renal cell carcinoma (mRCC) and soft tissue sarcoma (STS) at a ...
Diana Andreea Draghici,Alexandru Rares Stoian,Vlad Andrei Porojan et al. Diana Andreea Draghici et al.
Background: Rectal cancer is one of the most common malignant pathologies worldwide. Currently, the standard treatment of this pathology consists of radio-chemotherapy followed by low anterior resection with total mesorec...